News

November 15 - Dr. Anthony Tolcher joins the Scientific Advisory Board of NBE-Therapeutics

Read more

June 28 - Novo Holdings A/S invests CHF 20 million in a seriesB extension financing of NBE-Therapeutics

Read more

March 5 - USPTO grants US patent for NBE-Therapeutics' core conjugation technology

Read more